Rexit Berhad (KLSE:REXIT)

Elevation Oncology Revenue

Rexit Berhad had revenue of 7.91M MYR in the quarter ending March 31, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 31.73M, down -2.20% year-over-year. In the year 2024, Rexit Berhad had annual revenue of 32.19M with 0.37% growth.

• Revenue (ttm): 31.73M
• Revenue Growth: -2.20%
• P/S Ratio: 2.89
• Revenue / Employee: 341.23K
• Employees: 93
• Market Cap: 91.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.19M	118.33K	0.37%
Jun 30, 2024	32.07M	4.78M	17.50%
Jun 30, 2023	27.30M	1.09M	4.17%
Jun 30, 2022	26.20M	980.23K	3.89%
Jun 30, 2021	25.22M	-319.22K	-1.25%